Search Results - "KOSTNER, Gert M"

Refine Results
  1. 1

    Lipoprotein (a): a historical appraisal by Kostner, Karam M., Kostner, Gert M.

    Published in Journal of lipid research (01-01-2017)
    “…Initially, lipoprotein (a) [Lp(a)] was believed to be a genetic variant of lipoprotein (Lp)-B. Because its lipid moiety is almost identical to LDL, Lp(a) has…”
    Get full text
    Journal Article
  2. 2

    Is Lp(a) ready for prime time use in the clinic? A pros-and-cons debate by Kostner, Karam M., Kostner, Gert M., Wierzbicki, Anthony S.

    Published in Atherosclerosis (01-07-2018)
    “…Lipoprotein (a) (Lp(a)) is a cholesterol-rich lipoprotein known since 1963. In spite of extensive research on Lp(a), there are still numerous gaps in our…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Farnesoid X receptor represses hepatic human APOA gene expression by Chennamsetty, Indumathi, Claudel, Thierry, Kostner, Karam M, Baghdasaryan, Anna, Kratky, Dagmar, Levak-Frank, Sanja, Frank, Sasa, Gonzalez, Frank J, Trauner, Michael, Kostner, Gert M

    Published in The Journal of clinical investigation (01-09-2011)
    “…High plasma concentrations of lipoprotein(a) [Lp(a), which is encoded by the APOA gene] increase an individual's risk of developing diseases, such as coronary…”
    Get full text
    Journal Article
  6. 6

    Galactose-specific asialoglycoprotein receptor is involved in lipoprotein (a) catabolism by Hrzenjak, Andelko, Frank, Sasa, Wo, Xingde, Zhou, Yonggang, Van Berkel, Theo, Kostner, Gert M

    Published in Biochemical journal (15-12-2003)
    “…Lp(a) [lipoprotein (a)] is a highly atherogenic plasma lipoprotein assembled from low-density lipoprotein and the glycoprotein apolipoprotein (a). The rate of…”
    Get full text
    Journal Article
  7. 7

    FGF19 Signaling Cascade Suppresses APOA Gene Expression by Chennamsetty, Indumathi, Claudel, Thierry, Kostner, Karam M, Trauner, Michael, Kostner, Gert M

    “…OBJECTIVE—Lipoprotein(a) is a highly atherogenic lipoprotein, whose metabolism is poorly understood. Currently no safe drugs exists that lower elevated plasma…”
    Get full text
    Journal Article
  8. 8

    Submaximal stimulation of porcine endothelial cells causes focal Ca2+ elevation beneath the cell membrane by Graier, W F, Paltauf-Doburzynska, J, Hill, B J, Fleischhacker, E, Hoebel, B G, Kostner, G M, Sturek, M

    Published in The Journal of physiology (01-01-1998)
    “…Endothelial cell activation is correlated with increased cytosolic Ca 2+ concentration, often monitored with cytoplasmic Ca 2+ dyes, such as fura-2 and Calcium…”
    Get full text
    Journal Article
  9. 9

    Angiotensinogen Polymorphism M235T, Carotid Atherosclerosis, and Small-Vessel Disease-Related Cerebral Abnormalities by Schmidt, Reinhold, Schmidt, Helena, Fazekas, Franz, Launer, Lenore J, Niederkorn, Kurt, Kapeller, Peter, Lechner, Anita, Kostner, Gert M

    Published in Hypertension (Dallas, Tex. 1979) (01-07-2001)
    “…The angiotensinogen M235T polymorphism has been linked to hypertension and cardiovascular disease. We studied the role of this polymorphism as a risk factor…”
    Get full text
    Journal Article
  10. 10

    Defective uptake of triglyceride-associated fatty acids in adipose tissue causes the SREBP-1c-mediated induction of lipogenesis by Wagner, Elke M., Kratky, Dagmar, Haemmerle, Guenter, Hrzenjak, Andelko, Kostner, Gert M., Steyrer, Ernst, Zechner, Rudolf

    Published in Journal of lipid research (01-02-2004)
    “…Lipoprotein lipase (LPL) is the only known enzyme in the capillary endothelium of peripheral tissues that hydrolizes plasma triglycerides and provides fatty…”
    Get full text
    Journal Article
  11. 11

    Preparation of a stable fresh frozen primary lipoprotein[a] (Lp[a]) standard by Kostner, G M, Ibovnik, A, Holzer, H, Grillhofer, H

    Published in Journal of lipid research (01-12-1999)
    “…LP[a] is one of the most atherogenic lipoproteins consisting of an LDL-like core particle and a covalently linked glycoprotein of variable size. Due to its…”
    Get full text
    Journal Article
  12. 12

    Factors affecting plasma lipoprotein(a) levels: role of hormones and other nongenetic factors by Kostner, Karam M, Kostner, Gert M

    Published in Seminars in vascular medicine (01-05-2004)
    “…Lp(a) appears to be one of the most atherogenic lipoproteins. It consists of an low-density lipoprotein core in addition to a covalently bound glycoprotein,…”
    Get more information
    Journal Article
  13. 13

    Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis by Caplice, Noel M., Panetta, Carmelo, Peterson, Timothy E., Kleppe, Laurel S., Mueske, Cheryl S., Kostner, Gert M., Broze, George J., Simari, Robert D.

    Published in Blood (15-11-2001)
    “…Lipoprotein (a) [Lp(a)] has been associated with both anti-fibrinolytic and atherogenic effects. However, no direct link currently exists between this…”
    Get full text
    Journal Article
  14. 14

    Urinary excretion of apolipoprotein(a): relation to other plasma proteins by Kostner, Karam, Spitzauer, Susanne, Rumpold, Helmut, Maurer, Gerald, Knipping, Gabriele, Hrzenjak, Andelko, Frank, Sasa, Kostner, Gert M.

    Published in Clinica chimica acta (01-02-2001)
    “…The atherogenic lipoprotein Lp(a) consists of an LDL-like core and apo(a), linked to apoB via a thiol bridge. Apo(a) fragments ranging in size from 60 to 220…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Paraoxonase PON1 polymorphism Leu-Met54 is associated with carotid atherosclerosis : Results of the Austrian stroke prevention study by SCHMIDT, H, SCHMIDT, R, NIEDERKORN, K, GRADERT, A, SCHUMACHER, M, WATZINGER, N, HARTUNG, H.-P, KOSTNER, G. M

    Published in Stroke (1970) (01-10-1998)
    “…Genetic polymorphism at the paraoxonase locus is associated with serum concentration and activity of paraoxonase and with increased risk for coronary heart…”
    Get full text
    Conference Proceeding Journal Article
  17. 17

    MRI Cerebral White Matter Lesions and Paraoxonase PON1 Polymorphisms: Three-Year Follow-Up of the Austrian Stroke Prevention Study by Schmidt, Reinhold, Schmidt, Helena, Fazekas, NA, Kapeller, Peter, Roob, Gudrun, Lechner, Anita, Kostner, Gert M, Hartung, Hans-Peter

    “…White matter lesions (WMLs) on magnetic resonance imaging (MRI) scans of older persons are thought to be caused by cerebral small-vessel disease. As they…”
    Get full text
    Journal Article
  18. 18

    Angiotensinogen gene promoter haplotype and microangiopathy-related cerebral damage: Results of the Austrian Stroke Prevention Study by SCHMIDT, Helena, FAZEKAS, Franz, KOSTNER, Gert M, VAN DUIJN, Cornelia M, SCHMIDT, Reinhold

    Published in Stroke (1970) (01-02-2001)
    “…Microangiopathy-related cerebral damage (MARCD) is a common finding in the elderly. It may lead to cognitive impairment and gait disturbances. Arterial…”
    Get full text
    Journal Article
  19. 19

    Enhanced Association of Platelet-activating Factor Acetylhydrolase with Lipoprotein (a) in Comparison with Low Density Lipoprotein (∗) by Blencowe, Christopher, Hermetter, Albin, Kostner, Gert M., Deigner, Hans P.

    Published in The Journal of biological chemistry (29-12-1995)
    “…Paired samples of human Lipoprotein (a) (Lp(a)) and low density lipoprotein (LDL) were assayed for their platelet-activating factor (PAF) acetylhydrolase…”
    Get full text
    Journal Article
  20. 20